spondylosis. ???? ? ???? ??? ???? ??(??????????)
Conditions
Interventions
Intervention 1: Intervention group 1: Pentoprazole at a dose of 40 mg once daily for 8 weeks orally. Intervention 2: Intervention group 2: Famotidine at a dose of 40 mg once daily for 8 weeks orally.
Sponsors
Mazandaran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
30 Years to 65 Years
Inclusion criteria
Inclusion criteria: patients with degenerative disease requiring lumbar fusion surgery for spinal canal stenosis . patients with degenerative disease requiring lumbar fusion surgery for spondylolisthesis. patients with degenerative disease requiring lumbar fusion surgery for deformity. patients with degenerative disease requiring lumbar fusion surgery including discopathies .
Exclusion criteria
Exclusion criteria: Patients with low back injury due to trauma, infection, tumor, and inflammatory diseases, including rheumatoid arthritis Patients with diabetes Patients who smoke heavily A person's BMI is less than 20 or more than 35 Patients who do not have the consent to enter the study Patients with a history of osteoporosis are treated
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Bone fusion. Timepoint: Before, three and six months after surgery. Method of measurement: Radiology and CT scan. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactKaveh Haddadi
Mazandaran University of Medical Sciences
Outcome results
None listed